These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26154395)

  • 21. Factors related to training time and achieving proficiency with visual-assistive mobile applications in visually impaired older adults.
    Malkin AG; Bittner AK; Ho J; Idman-Rait C; Estabrook M; Ross NC;
    Optom Vis Sci; 2024 Jun; 101(6):351-357. PubMed ID: 38820379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the effectiveness of multidisciplinary low-vision rehabilitation.
    Wang BZ; Pesudovs K; Keane MC; Daly A; Chen CS
    Optom Vis Sci; 2012 Sep; 89(9):1399-408. PubMed ID: 22902419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study.
    Hsu WM; Cheng CY; Liu JH; Tsai SY; Chou P
    Ophthalmology; 2004 Jan; 111(1):62-9. PubMed ID: 14711715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a Portable Artificial Vision Device Among Patients With Low Vision.
    Moisseiev E; Mannis MJ
    JAMA Ophthalmol; 2016 Jul; 134(7):748-52. PubMed ID: 27148909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of eye care services and need for assistance in the visually impaired.
    Laitinen A; Koskinen S; Rudanko SL; Martelin T; Laatikainen L; Aromaa A
    Optom Vis Sci; 2008 May; 85(5):341-9. PubMed ID: 18451738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25.
    Stelmack JA; Stelmack TR; Massof RW
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2859-68. PubMed ID: 12202503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low vision with high aims.
    Adams AJ
    Optom Vis Sci; 2011 Nov; 88(11):1273. PubMed ID: 22032977
    [No Abstract]   [Full Text] [Related]  

  • 28. Abandonment of low-vision devices in an outpatient population.
    Dougherty BE; Kehler KB; Jamara R; Patterson N; Valenti D; Vera-Diaz FA
    Optom Vis Sci; 2011 Nov; 88(11):1283-7. PubMed ID: 21822160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vision rehabilitation for Canadians with less than 20/40 acuity: the SmartSight model.
    Jackson ML
    Can J Ophthalmol; 2006 Jun; 41(3):355-61. PubMed ID: 16767192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of reading speed after providing of low vision aids in patients with age-related macular degeneration.
    Nguyen NX; Weismann M; Trauzettel-Klosinski S
    Acta Ophthalmol; 2009 Nov; 87(8):849-53. PubMed ID: 19141148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life space limitations in visually impaired older adults.
    Bittner AK; Gobeille M; Malkin AG; Ho J; Idman-Rait C; Estabrook M; Ross NC;
    Optom Vis Sci; 2024 Jun; 101(6):321-328. PubMed ID: 38990234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing an instrumental activities of daily living tool as part of the low vision assessment of daily activities protocol.
    Finger RP; McSweeney SC; Deverell L; O'Hare F; Bentley SA; Luu CD; Guymer RH; Ayton LN
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8458-66. PubMed ID: 25425306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing the service potential of secondary level low vision clinics.
    Wong EY; O'connor PM; Keeffe JE
    Optom Vis Sci; 2011 Jul; 88(7):823-9. PubMed ID: 21499166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of portable electronic and optical magnifiers for near vision activities in low vision: a randomised crossover trial.
    Taylor JJ; Bambrick R; Brand A; Bray N; Dutton M; Harper RA; Hoare Z; Ryan B; Edwards RT; Waterman H; Dickinson C
    Ophthalmic Physiol Opt; 2017 Jul; 37(4):370-384. PubMed ID: 28497480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring outcomes of vision rehabilitation with the Veterans Affairs Low Vision Visual Functioning Questionnaire.
    Stelmack JA; Szlyk JP; Stelmack TR; Demers-Turco P; Williams RT; Moran D; Massof RW
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3253-61. PubMed ID: 16877389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and microperimetric predictors of reading speed in low vision patients: a structural equation modeling approach.
    Giacomelli G; Virgili G; Giansanti F; Sato G; Cappello E; Cruciani F; Varano M; Menchini U
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4403-8. PubMed ID: 23722392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vision rehabilitation: recipients' perceived efficacy of rehabilitation.
    Walter C; Althouse R; Humble H; Smith W; Odom JV
    Ophthalmic Epidemiol; 2007; 14(3):103-11. PubMed ID: 17613844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline traits of low vision patients served by private outpatient clinical centers in the United States.
    Goldstein JE; Massof RW; Deremeik JT; Braudway S; Jackson ML; Kehler KB; Primo SA; Sunness JS;
    Arch Ophthalmol; 2012 Aug; 130(8):1028-37. PubMed ID: 22893074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow fade. Help for low vision.
    Mayo Clin Womens Healthsource; 2009 Jun; 13(6):4-5. PubMed ID: 19415046
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy of low vision device training in a hospital-based low vision clinic.
    Pearce E; Crossland MD; Rubin GS
    Br J Ophthalmol; 2011 Jan; 95(1):105-8. PubMed ID: 20837788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.